Bio-Connect

InVivoMAb anti-mouse IFNgamma

BE0054
Bio X Cell
ApplicationsNeutralisation/Blocking
Product group Antibodies
ReactivityMouse
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Bio X Cell
  • Product Name
    InVivoMAb anti-mouse IFNgamma
  • Delivery Days Customer
    7
  • Applications
    Neutralisation/Blocking
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    R4-6A2
  • Concentration
    4-11 mg/ml
  • Estimated Purity
    >95%
  • Host
    Rat
  • Isotype
    IgG1
  • Reactivity
    Mouse
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • Clemente-Casares X, Blanco J, Ambalavanan P, et al. Expanding antigen-specific regulatory networks to treat autoimmunity. Nature. 2016,530(7591):434-40. doi: 10.1038/nature16962
    Read this paper
  • Conde P, Rodriguez M, van der Touw W, et al. DC-SIGN(+) Macrophages Control the Induction of Transplantation Tolerance. Immunity. 2015,42(6):1143-58. doi: 10.1016/j.immuni.2015.05.009
    Read this paper
  • Wensveen FM, Jelenčić V, Valentić S, et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol. 2015,16(4):376-85. doi: 10.1038/ni.3120
    Read this paper
  • Deligne C, Metidji A, Fridman WH, et al. Anti-CD20 therapy induces a memory Th1 response through the IFN-γ/IL-12 axis and prevents protumor regulatory T-cell expansion in mice. Leukemia. 2015,29(4):947-57. doi: 10.1038/leu.2014.275
    Read this paper
  • Maltby S, Hansbro NG, Tay HL, et al. Production and differentiation of myeloid cells driven by proinflammatory cytokines in response to acute pneumovirus infection in mice. J Immunol. 2014,193(8):4072-82. doi: 10.4049/jimmunol.1400669
    Read this paper
  • Hock K, Pilat N, Baranyi U, et al. Donor CD4 T cells trigger costimulation blockade-resistant donor bone marrow rejection through bystander activation requiring IL-6. Am J Transplant. 2014,14(9):2011-22. doi: 10.1111/ajt.12823
    Read this paper
  • Walsh KB, Teijaro JR, Brock LG, et al. Animal model of respiratory syncytial virus: CD8+ T cells cause a cytokine storm that is chemically tractable by sphingosine-1-phosphate 1 receptor agonist therapy. J Virol. 2014,88(11):6281-93. doi: 10.1128/JVI.00464-14
    Read this paper
  • Choi IK, Li Y, Oh E, et al. Oncolytic adenovirus expressing IL-23 and p35 elicits IFN-γ- and TNF-α-co-producing T cell-mediated antitumor immunity. PLoS One. 2013,8(7):e67512. doi: 10.1371/journal.pone.0067512
    Read this paper
  • Wu HY, Quintana FJ, da Cunha AP, et al. In vivo induction of Tr1 cells via mucosal dendritic cells and AHR signaling. PLoS One. 2011,6(8):e23618. doi: 10.1371/journal.pone.0023618
    Read this paper
  • Coley SM, Ford ML, Hanna SC, et al. IFN-gamma dictates allograft fate via opposing effects on the graft and on recipient CD8 T cell responses. J Immunol. 2009,182(1):225-33.
    Read this paper